At the request of Dr. S. E. Dryer, Molecular Pharmacology has retracted this article. A research misconduct investigation at the University of Houston initiated by Dr. Dryer found author misconduct in two other articles by the same authors [Abkhezr M and Dryer SE (2015) STAT3 Regulates Steady-State Expression of Synaptopodin in Cultured Mouse Podocytes Mol Pharmacol February 2015 87:231–239; doi:10.1124/mol.114.094508 and Abkhezr M, Kim EY, Roshanravan H, Nikolos F, Thomas C, Hagmann H, Benzing T, Dryer SE (2015) Pleiotropic signaling evoked by tumor necrosis factor in podocytes Am J Physiol Renal Physiol 309:F98–F108; doi:10.1152/ajprenal.00146.2015]. Because of the results of the investigation, Dr. Dryer has expressed concern over the validity of the work published in the above Molecular Pharmacology article and requested its retraction.
- Copyright © 2016 The American Society for Pharmacology and Experimental Therapeutics
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
- Notice of Retraction: Acharya P, Chen J-J, Correia MA (2010) Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2α kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol 77(4):575–592; doi:10.1124/mol.109.061259.
- Notice of Retraction: Acharya P, Engel JC, Correia MA (2009) Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2α (eIF2α)-kinase (PERK) and general control nonderepressible-2 eIF2α kinase (GCN2), and global translational shutoff. Mol Pharmacol 76(3):503–515; DOI: https://doi.org/10.1124/mol.109.056002.